Form 4 holding
Director
Atara Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 43,500
- Estimated value
- $16,922
- Report date
- 23 Jun 2022
- Price
- $0.3890
- Ownership
- Direct
Roy D. Baynes - Director at Atara Biotherapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Director
- Issuer Symbol
- ATRA on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Roy D. Baynes since 25 May 2025
Holdings reported by Roy D. Baynes for Atara Biotherapeutics, Inc.
Form 4 holding
Director
Atara Biotherapeutics, Inc.
- Security class
- Non-Qualified Stock Option (Right to Buy)
- Shares / value
- 31,500
- Estimated value
- Report date
- 23 Jun 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Roy D. Baynes for Atara Biotherapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.